A genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Zhou, Keke ^a,d   Hu, Dezhi ^a   Lu, Juan ^b   Fan, Weiwei ^b   Liu, Hongliang ^c   Chen, Hongyan ^b   Chen, Gong ^a   Wei, Qingyi ^c   Du, Guhong ^a   Mao, Ying ^a   Lu, Daru ^b   Zhou, Liangfu ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NONE   (China)

Author keywords

DNA repairgliomaAPE1 Ref 1association study; false positive report probability

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; GLYCINE; REDOX EFFECTOR FACTOR 1; THREONINE; APEX1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROMOTER REGION; ASIAN; BRAIN TUMOR; ETHNOLOGY; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POPULATION GENETICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; GLIOBLASTOMA; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; YOUNG ADULT;

EID: 79953114941     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-104     Document Type: Article

References (49)

1. Xue QC, Pu PY, Yang YS, Shen CH. A survey of 790 cases of astrocytoma. Clin Neurol Neurosurg 1990, 92(1):27-33. 10.1016/0303-8467(90)90004-O, 2154351.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005, 109(1):93-108. 10.1007/s00401-005-0991-y, 15685439.
3. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010, 60(3):166-193. 10.3322/caac.20069, 2888474, 20445000.
4. Fishel ML, Kelley MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 2007, 28(3-4):375-395. 10.1016/j.mam.2007.04.005, 17560642.
5. Demple B, Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 1994, 63:915-948. 10.1146/annurev.bi.63.070194.004411, 7979257.
6. Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000, 461(2):83-108.
7. Wilson DM, Barsky D. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat Res 2001, 485(4):283-307.
8. Xu YJ, Kim EY, Demple B. Excision of C-4'-oxidized deoxyribose lesions from double-stranded DNA by human apurinic/apyrimidinic endonuclease (Ape1 protein) and DNA polymerase beta. J Biol Chem 1998, 273(44):28837-28844. 10.1074/jbc.273.44.28837, 9786884.
9. Chou KM, Kukhanova M, Cheng YC. A novel action of human apurinic/apyrimidinic endonuclease: excision of L-configuration deoxyribonucleoside analogs from the 3' termini of DNA. J Biol Chem 2000, 275(40):31009-31015. 10.1074/jbc.M004082200, 10906132.
10. Chou KM, Cheng YC. An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3' mispaired DNA. Nature 2002, 415(6872):655-659. 10.1038/415655a, 11832948.
11. Tell G, Damante G, Caldwell D, Kelley MR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?. Antioxid Redox Signal 2005, 7(3-4):367-384. 10.1089/ars.2005.7.367, 15706084.
12. Ludwig DL, MacInnes MA, Takiguchi Y, Purtymun PE, Henrie M, Flannery M, Meneses J, Pedersen RA, Chen DJ. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat Res 1998, 409(1):17-29.
13. Bapat A, Fishel ML, Kelley MR. Going ape as an approach to cancer therapeutics. Antioxid Redox Signal 2009, 11(3):651-668. 10.1089/ars.2008.2218, 2787666,2787666, 18715143.
14. Hadi MZ, Coleman MA, Fidelis K, Mohrenweiser HW, Wilson DM. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res 2000, 28(20):3871-3879. 10.1093/nar/28.20.3871, 110798, 11024165.
15. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001, 22(6):917-922. 10.1093/carcin/22.6.917, 11375899.
16. Mitra AK, Singh N, Singh A, Garg VK, Agarwal A, Sharma M, Chaturvedi R, Rath SK. Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in North Indian women. Oncol Res 2008, 17(3):127-135.
17. Canbay E, Agachan B, Gulluoglu M, Isbir T, Balik E, Yamaner S, Bulut T, Cacina C, Eraltan IY, Yilmaz A, et al. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res 2010, 30(4):1359-1364.
18. Li C, Liu Z, Wang LE, Strom SS, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, et al. Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 2006, 27(9):1894-1901. 10.1093/carcin/bgl042, 16621887.
19. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M, Aldape KD, Wei Q, Etzel C, Bondy ML. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 2009, 18(1):204-214. 10.1158/1055-9965.EPI-08-0632, 2917049, 19124499.
20. Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol 2006, 175(1):108-112. discussion 112, 10.1016/S0022-5347(05)00042-X, 16406883.
21. Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, Li D. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev 2006, 30(3):284-291. 10.1016/j.cdp.2006.05.002, 1857309, 16844323.
22. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P, Razavi P, Patoka J, Wiencke JK, Bondy ML, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1118-1126. 10.1158/1055-9965.EPI-08-1078, 2667563, 19318434.
23. Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, Welch R, Chanock S, Keohavong P, Donahue M, et al. Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res 2005, 25(1B):537-542.
24. Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR, Albanes D. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 2003, 191(2):171-178. 10.1016/S0304-3835(02)00638-9, 12618330.
25. Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 2004, 25(8):1395-1401. 10.1093/carcin/bgh153, 15044328.
26. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004, 25(12):2433-2441. 10.1093/carcin/bgh264, 15333465.
27. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27(3):560-567. 10.1093/carcin/bgi232, 16195237.
28. Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, et al. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009, 18(1):223-229. 10.1158/1055-9965.EPI-08-0749, 19124501.
29. Lu J, Zhang S, Chen D, Wang H, Wu W, Wang X, Lei Y, Wang J, Qian J, Fan W, et al. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J 2009, 23(10):3459-3469. 10.1096/fj.09-136549, 19541747.
30. Wang C, Mao Y, Zhu JH, Zhou LF. The Department of Neurosurgery at Shanghai Huashan Hospital. Neurosurgery 2008, 62(4):947-952. discussion 952-943, 10.1227/01.neu.0000318181.80040.99, 18496201.
31. Jurinke C, van den Boom D, Cantor CR, Koster H. Automated genotyping using the DNA MassArray technology. Methods Mol Biol 2002, 187:179-192.
32. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96(6):434-442. 10.1093/jnci/djh075, 15026468.
33. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009, 41(8):899-904. 10.1038/ng.407, 19578367.
34. Simon M, Hosking FJ, Marie Y, Gousias K, Boisselier B, Carpentier C, Schramm J, Mokhtari K, Hoang-Xuan K, Idbaih A, et al. Genetic risk profiles identify different molecular etiologies for glioma. Clin Cancer Res 2010, 16(21):5252-5259. 10.1158/1078-0432.CCR-10-1502, 20847058.
35. Fishel ML, He Y, Reed AM, Chin-Sinex H, Hutchins GD, Mendonca MS, Kelley MR. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) 2008, 7(2):177-186. 10.1016/j.dnarep.2007.09.008, 2247410, 17974506.
36. Luo M, Delaplane S, Jiang A, Reed A, He Y, Fishel M, Nyland RL, Borch RF, Qiao X, Georgiadis MM, et al. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 2008, 10(11):1853-1867. 10.1089/ars.2008.2120, 2587278,2587278, 18627350.
37. Zou GM, Maitra A. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther 2008, 7(7):2012-2021. 10.1158/1535-7163.MCT-08-0113, 18645011.
38. Bobola MS, Blank A, Berger MS, Stevens BA, Silber JR. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas. Clin Cancer Res 2001, 7(11):3510-3518.
39. Wilkie GS, Dickson KS, Gray NK. Regulation of mRNA translation by 5'- and 3'-UTR-binding factors. Trends Biochem Sci 2003, 28(4):182-188. 10.1016/S0968-0004(03)00051-3, 12713901.
40. De Gobbi M, Viprakasit V, Hughes JR, Fisher C, Buckle VJ, Ayyub H, Gibbons RJ, Vernimmen D, Yoshinaga Y, de Jong P, et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 2006, 312(5777):1215-1217. 10.1126/science.1126431, 16728641.
41. Buckland PR. The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochim Biophys Acta 2006, 1762(1):17-28.
42. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman N, Linet MS, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 2010, 12(1):37-48. 2940551, 20150366.
43. Zhou K, Liu Y, Zhang H, Liu H, Fan W, Zhong Y, Xu Z, Jin L, Wei Q, Huang F, et al. XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int J Cancer 2009, 124(12):2948-2953. 10.1002/ijc.24307, 19330829.
44. Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, Xu Z, Zhong Y, Liu H, Jin L, Wei Q, et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 2008, 29(3):381-389. 10.1002/humu.20645, 18165945.
45. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Sison JD, Aldape K, McMillan A, Wiemels J, Wiencke JK. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol 2005, 7(4):495-507. 10.1215/S1152851705000037, 1871723, 16212814.
46. Yang P, Kollmeyer TM, Buckner K, Bamlet W, Ballman KV, Jenkins RB. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas. Cancer 2005, 103(11):2363-2372. 10.1002/cncr.21028, 15834925.
47. Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, Pudavalli V, Levin VA, Yung WK, Wei Q. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 2004, 64(16):5560-5563. 10.1158/0008-5472.CAN-03-2181, 15313891.
48. Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, Tsavachidis S, Liang FW, Gilbert M, Aldape K, et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol 2010, 28(14):2467-2474. 10.1200/JCO.2009.26.6213, 20368557.
49. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009, 41(8):905-908. 10.1038/ng.408, 2923561, 19578366.